AI-powered search
AI-powered search

Live Evaluations

Prurigo Nodularis: Managing the ‘Itch-Scratch Cycle’ with Biologics

About

Prurigo Nodularis: Managing the ‘Itch-Scratch Cycle’ with Biologics

This activity is supported by educational grants from Galderma and Sanofi and Regeneron Pharmaceuticals.

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Describe the impact of PN on patient quality of life, including sleep quality and mental health

  • Review efficacy and safety data for approved and emerging biologics to manage PN

  • Discuss patient-centered strategies for integrating new and emerging biologics for PN into clinical care

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Raj
Raj Chovatiya, MD, PhD, MSCI

Clinical Associate Professor, Rosalind Franklin University Chicago Medical School Founder and Director, Center for Medical Dermatology and Immunology Research 
Chicago, IL

Shawn
Shawn Kwatra, MD

Director 
Johns Hopkins Itch Center 
Associate Professor 
The John Hopkins University School of Medicine 
Baltimore, MD

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Raj Chovatiya, MD, PhD, MSCI

Consultant: AbbVie, Arcutis, Arena, Argenx, Beiersdorf, Bristol Myers Squibb, Dermavant, Eli Lilly and Company, EPI Health, Incyte, LEO Pharma, L’Oréal, National Eczema Association, Pfizer Inc., Regeneron, Sanofi, and UCB

Speakers’ Bureau or Honoraria: AbbVie, Arcutis, Dermavant, Eli Lilly and Company, Incyte, LEO Pharma, Pfizer Inc., Regeneron, Sanofi, and UCB

Shawn Kwatra, MD

Advisory Board: Abbvie, Amgen, Arcutis, Aslan Pharmaceuticals, Cara Therapeutics, Castle Biosciences, Celldex Therapeutics, Galderma, Incyte Corporation, Johnson & Johnson, Novartis, Leo, Regeneron, Sanofi Grant/Research Support: Galderma, Incyte, Pfizer, and Sanofi

Consultant: Abbvie, Amgen, Arcutis, Aslan Pharmaceuticals, Cara Therapeutics, Castle Biosciences, Celldex Therapeutics, Galderma, Incyte Corporation, Johnson & Johnson, Novartis, Leo, Regeneron, Sanofi

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved